Diagnostic markers.
There are disclosed protein molecules that provide noel targets for the development of therapeutics of human leukemia. These protein molecules are forkhead transcription factor (FKHR) and proapoptotic member of the Bcl-2 family (bad) of the phosphoinositide 3-Kinase pathway and p38 and JUN-terminal...
Principais autores: | Seow, Heng Fong, Abdullah, Maha |
---|---|
Formato: | Patent |
Publicado em: |
2009
|
Registros relacionados
-
Prognostic Markers Of Resistance And Relapse In Acute Leukaemia
por: Pon, Maha Abdullah@Maha-Lakswmi
Publicado em: (2003) -
Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
por: Abdullah, Maha, et al.
Publicado em: (2009) -
Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome
por: Abdullah, Maha, et al.
Publicado em: (2008) -
S-phase fraction and pro-inflammatory cytokine expressions in acute lymphoblastic leukaemia
por: Abdullah, Maha, et al.
Publicado em: (2005) -
An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease
por: Zahari Sham, Siti Yazmin, et al.
Publicado em: (2022)